Form 4 for CVKD Cadrenal Therapeutics, Inc.
Accepted 2025-10-14 00:00:00 ET · period of report 2025-10-09 · accession 0001213900-25-098718 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-10-14 | 2025-10-09+ | CVKD | Szot Matthew K | CFO | S - Sale | $14.03 | -3,493 | 13.5K | -21% | -$49.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-09 | S | D | 1,693 | $13.99 | 15,333 | D | — | — | (F1) Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement. |
| 2 | Common | Common Stock | 2025-10-13 | S | D | 1,800 | $14.07 | 13,533 | D | — | — | (F1) Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement. |